Cargando…
Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics
Diabetic kidney disease (DKD) affects an estimated 20–40% of type 2 diabetes patients and is among the most prevalent microvascular complications in this patient population, contributing to high morbidity and mortality rates. Currently, changes in albuminuria status are thought to be a primary indic...
Autores principales: | Wei, Lan, Han, Yuanyuan, Tu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842482/ https://www.ncbi.nlm.nih.gov/pubmed/36760602 http://dx.doi.org/10.2147/DMSO.S392888 |
Ejemplares similares
-
Molecular pathways that drive diabetic kidney disease
por: Mohandes, Samer, et al.
Publicado: (2023) -
Inferring Active Metabolic Pathways from Proteomics and Essentiality Data
por: Montero-Blay, Ariadna, et al.
Publicado: (2020) -
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
por: Pena, Michelle J., et al.
Publicado: (2016) -
Molecular Mechanisms of Diabetic Kidney Disease
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2022) -
Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease
por: Zhou, Kaixuan, et al.
Publicado: (2022)